DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Motzer R, Escudier B, Oudard S.
RAD001 vs. placebo in patients with metastatic renal cell carcinoma (RCC) after progression on VEGFR-TKI therapy: Results from a randomized, double-blind, multicenter Phase-III study.
In: J Clin Oncol.
2008
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.